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Cyclic ADP-ribose (cADPR), an endogenous NAD+ metabolite in many mammalian and invertebrate tissues, is a potent mediator of calcium 
mobilization in sea urchin eggs. Our results show that cADPR also stimulates calcium release from rat brain microsomes, marked release occurring 
over the concentration range 10-250 nM. This is not inhibited by concentrations of heparin which completely abolish inositol 1,4,5&sphosphate 
(IP,)-induced Ca*’ release. Ryanodine (100 PM) inhibits the cADPR response. Our results are consistent with cADPR being an endogenous 
messenger mediating Ca” release from ryanodine-sensitive pools in brain. 
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1. INTRODUCTION results are consistent with a general role for cADPR as 
a physiological igand for ryanodine receptors. 
IP3 is well established as a second messenger regulat- 
ing Ca*+ release from intracellular stores [l]. Its recep- 
tor, which is itself a Ca*’ channel, has been purified to 
homogeneity from several tissues and has been cloned 
[2]. In addition to IP, receptors, a second class of intra- 
cellular Ca*’ channel has been identified the activity of 
which can be modulated by the plant alkaloid, ryan- 
odine. Ryanodine receptors are the major release chan- 
nels in muscle where they are important in excitation 
coupling [4]. They are also present in other tissues, nota- 
bly brain [5-S]. They are often activated by caffeine but 
insensitive to IP,. The physiological igand for receptor 
activation is unknown, although they can be activated 
by Ca*‘, so-called Ca*‘-induced Ca*+ release (CICR) [4]. 
One candidate is an NAD’ metabolite, cyclic ADP- 
ribose (cADPR), which has been shown to be as potent 
as IP, at releasing Ca’+ in sea-urchin eggs [9]. Recent 
work on homogenates prepared from sea-urchin eggs 
suggests that cADPR may be operating on a CICR 
mechanism mediated by a ryanodine receptor [lo, 111. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
45CaCl, was obtained from NEN DuPont. Fluo-3 was from Calbio- 
them. All other reagents were purchased from Sigma. Cyclic ADP- 
ribose was a generous gift from Dr. Hon Cheung Lee, University of 
Minnesota, USA. 
2.2. Microsome preparation 
cADPR is a naturally occurring nucleotide, cytosolic 
concentrations in rat liver, brain and heart ranging be- 
tween 20 and 100 nM [12]. The widespread occurrence 
of cADPR in mammalian tissues suggests that its effi- 
cacy as a Ca*‘-mobilizing agent might not be restricted 
to invertebrate eggs. Indeed, cADPR has been shown 
recently to release Ca*+ through an IP,-insensitive 
mechanism in GH,CI cells and dorsal root ganglion 
cells [13,14]. The present study shows that cADPR in- 
duces Ca*’ release from rat brain microsomes and that 
this release is sensitive to inhibition by ryanodine. These 
Microsomes were prepared essentially as described in [lS]. Whole 
brains from male Wistar rats (250-300 g) were homogenized gently (5 
strokes of a glass homogeniser) in 9 ~01s. of ice-cold buffer consisting 
of N-methylglucamine (250 mM), potassium gluconate (250 mM), 
HEPES (20 mM), MgCl, (1 mM), soybean trypsin inhibitor (100 
&ml), aprotinin (20 ,@ml), leupeptin (25 &ml) at pH 7.2. The 
homogenate was centrifuged (1,000 x g, 5 min) and the supernatant 
retained whilst the pellet was washed with 10 ml buffer. Supematants 
were combined and centrifuged at 8,000 x g for 10 min. The supema- 
tant was then centrifuged at 100,000 x g for 40 min. The microsomal 
pellet obtained was resuspended gently in an equal volume of homog- 
enization buffer containing ATP (1 mM) and an ATP-regenerating 
system consisting of phosphocreatine (10 mM), creatine phosphoki- 
nase (10 U/ml), oligomycin (1 &ml), antimycin (1 j&ml) and sodium 
azide (1 mM); it was diluted to a final protein concentration of 0.5 
mg/ml for fluorimetry. 
2.3. Ca-” release measurements 
Rat brain microsomes were always prepared on the day of the 
experiment. Loading of microsomes with Ca*+ took approximately 30 
min at room temperature (Fig. 2a). Ca*’ uptake and release was 
followed by monitoring extra-microsomal Car’ using fluo-3 (1 PM). 
Fluorescence intensity of fluo-3 was measured at excitation and emis- 
sion wavelengths of 490 nm and 535 nm, respectively. Fluorimetry was 
performed on 500 ~1 aliquots of microsomes using a Perkin-Elmer 
LS-3. Additions were made in volumes of 1-5~1 and all chemicals were 
added in incubation medium containing 10 ,uM EGTA. Ca2’ traces 
were calibrated by adding Ca2’ standard solution. 
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described above but in the presence of 1 pCi/ml %aCl,. Microsomal 
“Ca2’ was determined by removing 50~1 aliquots at appropriate time 
intervals and filtering rapidly through Whatman GFlB filters. Filters 
were washed with 2 x 2.5 ml ice-cold wash buffer consisting of N- 
methylglucamine (250 mM), potassium gluconate (250 mM) and 20 
mM HEPES at pH 7.2. Radioactivity was determined by liquid scintil- 
lation counting. 
3. RESULTS AND DISCUSSION 
cADPR induced Ca” release from brain microsomes 
in a concentration-dependent manner with a threshold 
concentration of less than 10 nM (Fig. la). A maximally 
effective concentration of 250 nM cADPR elicited 24 
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nmol Ca2’ release and in several experiments at this 
concentration, Ca” was only slowly (> 15 min) re-se- 
questered into the microsomes. Heating cADPR for 40 
min at 95°C completely destroyed its Ca”-releasing ac- 
tivity (Fig. lb). Heat treatment for 10 min caused only 
partial inactivation. The non-cyclic analogue, ade- 
nosine 5’-diphosphoribose (250 nM), did not cause Ca” 
release and did not inhibit cADPR-induced release of 
Ca2’ (Fig. lc). /?-NAD, the precursor of cADPR, exhib- 
ited no Ca2’-releasing activity at concentrations as high 
as 50 PM (Fig. Id). Fig. le shows that cADPR-induced 
Ca2’ release is inhibited by pretreatment with cADPR. 
This apparent desensitization is restricted to cADPR, 
cADPR(1 OnM) cADPR (250 nM) 
I 
2 nmol Ca2’ 
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Heated cADPR 
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Fig. 1. cADPR-induced Ca*’ release from rat whole brain microsomes measured by fluo-3 fluorescence. Ca*‘-loaded microsomes were prepared 
as described in Materials and Methods and used at a final protein concentration of 0.5 mg/ml for fluorimetry. Representative traces of 2-3 
experiments are shown. (a) cADPR elicits a rapid Ca” release. (b) 250 nM heat-treated cADPR (95’C, 40 min) does not release Ca2’ (c) The 
non-cyclic analogue, adenosine 5’-diphosphoribose, causes no increase in fluorescence. (d) 5 PM B-NAD causes no Ca” release. (e) Brain 
microsomes can be desensitized to cADPR-induced Ca*’ release by repeated cADPR additions. 
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Fig. 2. ?a’+ release from brain microsomes. (a) Microsomes (approx. protein concentration 0.5 mg/ml) were loaded with Wa2+ (1 @.X/ml) for 
30 min as described in Materials and Methods. (b) %a’+ release licited by 12 ,uM IP,. (c) a5Caz* release licited by 250 nM cADPR. (d) 100 PM 
ryanodine causes “%Za” release from microsomes. Subsequent addition of 250 nM cADPR has no effect. 
the microsomes remaining responsive to IP,. A similar 
desensitization has been observed in sea-urchin eggs 
[16]. These effects were corroborated by measuring 
45Ca2+ release from microsomes. Up to 60% of 45Ca2+ 
could be released from microsomes by a maximal con- 
centration of IP, (Fig. 2b). 250 nM cADPR caused an 
approximately 20% release of 45Ca2’ release (Fig. 2~). 
100 PM ryanodine caused a 20% release of sequestered 
45Ca2+ (Fig. 2d); cADPR elicited no further release. 
To determine whether cADPR acted on the IP, recep- 
tor or at a site that was independent of IP,, microsomes 
were pretreated with heparin, a competitive inhibitor of 
IP, binding. IP, (200 nM) elicited 2.5 nmol Ca” release 
(Fig. 3a). The presence of 600 ,@ml heparin completely 
blocked Ca” release by 200 nM IP,, but had no effect 
on cADPR-induced Ca*’ release (Fig. 3b). 
It has been suggested that cADPR may act through 
a Ca”-induced Ca*’ release (CICR) mechanism. 
Galione et al. [lo] showed that treatment of sea-urchin 
egg homogenate with caffeine and ryanodine elicited a 
Ca*+ response which induced desensitization of the re- 
sponse to cADPR but not to IP,. Figs. 2d and 3c show 
that pretreatment of rat brain microsomes with 100 ,uM 
ryanodine also inhibits release of Ca2’ by cADPR but 
not that induced by IP,. This result is consistent with the 
demonstration that cADPR mimics caffeine but not IP, 
in inducing oscillations in a Ca*+-dependent ion current 
known to reflect intracellular Ca2’ oscillations in rat 
dorsal root ganglion [14]. 
In conclusion, our results suggest hat cADPR may 
be an important physiological modulator of IP,-insensi- 
tive Ca2+ release in brain. This mechanism appears to 
involve ryanodine channels. The function of neuronal 
ryanodine receptors in contrast to their counterparts in 
muscle, is unclear. However, CICR through these re- 
ceptors may be important in amplifying neuromodula- 
tory Ca” signals in processes such as memory and 
learning [ 171. 
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Fig. 3. Pretreatment with ryanodine inhibits Ca’+ release induced by cADPR but heparin has no effect. Ca2+ release from microsomes was performed 
as described in Fig. 1. (a) In the absence of heparin 200 nM IP, elicits 2.5 nmol Ca’+ release. (b) Pretreatment of microsomes with 600pglml heparin 
completely blocks release of Ca” by IP, (200 nM) but does not affect cADPR-induced Car’ release. (c) 100 PM ryanodine causes rapid release 
of Ca” which is re-sequestered. Subsequent addition of cADPR (250 nM) causes no release. however, microsomes remain sensitive to IP,. 
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